Expressions of the CIP/KIP Family of CDK Inhibitor Proteins in Primary Intestinal Large B-cell Lymphomas: Correlation with Clinical Outcomes
- 1 January 2002
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 198 (11) , 741-746
- https://doi.org/10.1078/0344-0338-00330
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Aberrant DNA methylation ofp57KIP2 gene in the promoter region in lymphoid malignancies of B-cell phenotypeBlood, 2002
- Expression Pattern of p27 Protein in Primary Gastric LymphomasCancer Research and Treatment, 2001
- Expression of cell cycle regulators p57KIP2, cyclin D1, and cyclin E in epithelial ovarian tumors and survivalHuman Pathology, 2001
- Reduced p21WAF1/CIP1 expression is an early event in gallbladder carcinogenesis and is of prognostic significance for patients with carcinomas of the gallbladderHuman Pathology, 2001
- Cyclin-dependent kinase inhibitors--a novel class of prognostic indicators.Human Pathology, 2001
- Overall Survival in Aggressive B-Cell Lymphomas Is Dependent on the Accumulation of Alterations in p53, p16, and p27The American Journal of Pathology, 2001
- Expressions of p53 and p21 in Primary Gastric LymphomasJournal of Korean Medical Science, 2001
- Aberrant p27Kip1 promoter methylation in malignant melanomaOncogene, 2000
- MALIGNANT TUMORS OF THE STOMACH: Gastric Mucosa-Associated Lymphoid Tissue Lymphoma and Helicobacter pyloriGastroenterology Clinics of North America, 2000
- The Cyclin-Dependent Kinase Inhibitor p21WAF1 Is Required for Survival of Differentiating Neuroblastoma CellsMolecular and Cellular Biology, 1996